Abstract
Implementation and effects of clinical rehabilitation pathway in the recovery stage of ischemic stroke
  
DOI:
EN KeyWords: stroke  clinical rehabilitation pathway  activities of daily living  length of hospital stay
Fund Project:佛山市科技局医学类科技攻关项目(2014AB00268);科技创新平台建设项目(2016AG100421)
作者单位
张盘德 佛山市第一人民医院康复医学科广东 佛山 528000 
刘鑫鑫 佛山市第一人民医院康复医学科广东 佛山 528000 
周惠嫦 佛山市第一人民医院康复医学科广东 佛山 528000 
黄文清 佛山市第一人民医院康复医学科广东 佛山 528000 
刘震 佛山市第一人民医院康复医学科广东 佛山 528000 
张薇平 佛山市第一人民医院康复医学科广东 佛山 528000 
View Counts: 9703
PDF Download Counts: 7865
EN Abstract:
  Objective: To institute the implementation plan of clinical rehabilitation pathway on convalescent stroke patients and evaluate its efficacy. Methods: The rehabilitation clinical pathway was instituted on convalescent stroke patients according to Delphi method. Based on a retrospective study, the length of hospital stay, hospital expense and rehabilitation outcome (Activities of Daily Living in Barthel Index, Holden walking ability and hand ability) were compared between 176 convalescent stoke patients managed according to the clinical rehabilitation pathway and 142 stroke patients receiving traditional treatment. Results: The length of hospital stay in clinical pathway group (15.27±7.16 days) was significantly shorter than in the control group (17.16±9.51 days) (P=0.018). The hospital expense (15078.45±6893.69 CNY) in clinical pathway group was significantly less than in the control group (16238.15±9576.28 CNY) (P=0.027). What's more, rehabilitation outcome including Activities of daily living in Bathel Index, Holden walking ability and hand ability had no statistically significant difference between two groups. The variation rate of clinical pathway was 22.1% (39/176 cases) in clinical pathway group. Conclusions: The hospital expense was much less and the length of hospital stay was shorter in clinical pathway group than in the control group. Even then, clinical pathway group patients achieved the same rehabilitation outcome as the control group patients. However, there was a high variation rate in the clinical pathway group. It is necessary to optimize the clinical pathway before it is adapted into clinical practice.
查看全文   Download PDF Reader  HTML Full Text
Close
本刊微信二维码